|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 17933-00012
|
||||||||
|
6. House ID# 312630000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: DAVID WIERMANSKI |
Date | 7/10/2018 3:30:41 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 5138 "Bipartisan Health Savings Accounts (HSAs) Improvement Act"
H.R. 5625 "Easy Enrollment Act"
H.R. 1876 "Good Samaritan Health Professionals Act"
S. 2278 "State Offices of Rural Health Reathorization Act"
H.R. 5674 "VA Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act"
H.R. 5102 "Substance Use Disorder Workforce Loan Repayment Act"
H.R. 5261 "Treatment, Education, and Community Help to Combat Addiction Act"
S. 2680 "Opioid Crisis Response Act" which included S. 1850 "Jessie's Law"
S. 2597 "Children's Hospital GME Support Reauthorization Act"
S. 2852 "Pandemic and All-Hazards Preparedness and Advancing Innovation Act"
S. 204 "Right to Try Act"
H.R. 2026 "Pharmaceutical Information Exchange (PIE) Act"
H.R. 5795 "Overdose Prevention and Patient Safety Act"
H.R. 3545 "Overdose Prevention and Patient Safety Act"
H.R. 6082 "Overdose Prevention and Patient Safety Act"
H.R. 4613 "Ensuring Access to Patient Healthcare Records Act"
S. 1732 "Improving Access to Behavioral Health Information Technology Act"
H.R. 5603 "Access to Telehealth Services for Opioid Use Disorder Act"
H.R. 5483 "Special Registration for Telemedicine Clarification Act"
H.R. 2 "Agricultural and Nutrition Act"
S. 925 "Veterans in E-Health and Telemedicine Support Act" (H.R. 2123)
S. 2315 "Over-the-Counter Drug Safety, Innovation, and Reform Act"
H.R. 2953 / S. 2164 a bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings
S. 1028 RAISE Family Caregivers Act (P.L. 115-119)
S. 445 "home Health Planning Improvement Act"
H.R. 1617 "Promoting Access to Diabetic Shoes Act"
H.R. 5385 "Children's Hospital GME Support Reauthorization Act"
S. 2483 "Opioid Workforce Act"
H.R. 5176 "Preventing Overdoses while in Emergency Rooms (POWER) Act of 2018"
H.R. 5327 "Comprehensive Opioid Recovery Centers (CORC) Act of 2018"
H.R. 5261 "Training, Education, and Community Help (TEACH) to Combat Addiction Act of 2018"
H.R. 5695 "Emmett's Law"
H.R. 5735 "Transitional Housing for Recovery in Viable Environments (THRIVE) Act"
H.R. 5041 "Safe Disposal of Unused Medication Act"
H.R. 4684 "Ensuring Access to Quality Sober Living Act of 2018"
H.R. 5587 "Peer Support Communities of Recovery Act"
H.R. 449 "Synthetic Drug Awareness Act"
H.R. 4275 "Empowering Pharmacists in the Fight Against Opioid Abuse Act"
H.R. 5197 "Alternatives to Opioids (ALTO) in the Emergency Department Act"
H.R. 6 "Support for Patients and Communities Act"
H.R. 1565 "Saving Lives, Saving Costs Act"
S. 1850 "Protecting Jessica Grubb's Legacy Act"
P.L. 115-141 omnibus appropriations
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4841 "Standardizing Electronic Prior Authorization for Safe Prescribing Act"
H.R. 592 "Pharmacy and Medically Underserved Areas Enhancement Act"
S. 109 "Pharmacy and Medically Underserved Areas Enhancement Act"
H.R. 2687 "Medicaid Coverage for Addiction Recovery Expansion (CARE) Act"
H.R. 1953 / S. 830 "Treat and Reduce Obesity Act"
H.R. 1892 "Bipartisan Budget Act of 2018" (P.L. 115-123)
H.R. 4006 "Community-Based Independence for Seniors Act"
H.R. 2687 "Medicaid Coverage for Addiction Recovery Expansion (CARE) Act"
H.R. 5768 "Expanding Access to DSMT Act of 2018"
H.R. 1953 "Treat and Reduce Obesity Act"
S. 830 "Treat and Reduce Obesity Act"
H.R. 908 "Medicare Advantage Quality Payment Relief Act"
S. 1301 "Resident Physician Shortage Reduction Act"
P.L. 115-120 (H.R.195)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Congressional Budget Office (CBO), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |